PSMA-PET Guided Treatment in Prostate Cancer Patients with Oligorecurrent Progression after Previous Salvage Treatment

SIMPLE SUMMARY: Prostate Specific Membrane Antigen-Positron Emission Tomography (PSMA-PET) is currently recommended to stage Prostate Cancer (PCa) patients with recurrent disease and to select patients for metastasis-directed therapy (MDT). We aimed to evaluate the oncologic outcomes of second-line...

Descripción completa

Detalles Bibliográficos
Autores principales: Bianchi, Lorenzo, Ceci, Francesco, Balestrazzi, Eleonora, Costa, Francesco, Droghetti, Matteo, Piazza, Pietro, Pissavini, Alessandro, Presutti, Massimiliano, Farolfi, Andrea, Mei, Riccardo, Castellucci, Paolo, Gandaglia, Giorgio, Larcher, Alessandro, Robesti, Daniele, Mottrie, Alexandre, Briganti, Alberto, Morganti, Alessio Giuseppe, Fanti, Stefano, Montorsi, Francesco, Schiavina, Riccardo, Brunocilla, Eugenio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093227/
https://www.ncbi.nlm.nih.gov/pubmed/37046687
http://dx.doi.org/10.3390/cancers15072027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093227/
https://www.ncbi.nlm.nih.gov/pubmed/37046687
http://dx.doi.org/10.3390/cancers15072027

Ejemplares similares